Daewoong Co., Ltd. (KRX:003090)

Market Cap	1.18T +38.6%
Revenue (ttm)	2.06T +9.4%
Net Income	77.51B -37.2%
EPS	1,895.73 -37.3%
Shares Out	40.89M
PE Ratio	15.24
Forward PE	n/a
Dividend	200.00 (0.70%)
Ex-Dividend Date	Dec 29, 2025

Volume	194,430
Average Volume	161,483
Open	28,850
Previous Close	28,550
Day's Range	28,150 - 29,950
52-Week Range	17,420 - 30,600
Beta	0.43
RSI	69.30
Earnings Date	Mar 6, 2026

About Daewoong

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam-si, So...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 379
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003090

Financial Performance

In 2024, Daewoong's revenue was 1.94 trillion, an increase of 6.79% compared to the previous year's 1.81 trillion. Earnings were 57.89 billion, a decrease of -62.08%.